Coronary/Structural Heart Boston Scientific says Lotus out until Next Year Share by Ken Dropiewski on February 2, 2018 More in Coronary/Structural Heart: AQUAPASS REFORM-HF Pivotal Trial Meets Primary Endpoint, Demonstrating Significant Fluid Removal in Heart Failure Patients November 5, 2026 Cleerly to Present Late-Breaking Results from the First Randomized Trial of AI-QCT-Guided Care in Patients with Stable Chest Pain at AHA 2026 November 5, 2026 Murj® Surpasses 1 Million Patients Actively Managed on Its Cardiac Device Management Platform November 5, 2026 Share this story Facebook Twitter LinkedIn Lotus Valve to Stay Off the Shelves Through 2018 Patrice Wendling – February 01, 2018, Medscape MARLBOROUGH, MA — The beleaguered Lotus heart valve system is not expected to launch in the US market until 2019, according to Boston Scientific officials. All Lotus valves were voluntarily recalled worldwide in February 2017 because of reports of early release of a pin connecting the transcatheter valve to the delivery system…. Read Full Article at Medscape here